Subscribe to MDT Magazine News

Breast Implants: FDA Review Indicates Possible Association With A Rare Cancer

January 26, 2011 6:37 am | by U.S. Food & Drug Administration | Comments

Data reviewed by the FDA suggest that patients with breast implants may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant.

FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants

January 26, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

The FDA is issuing this communication to inform health care providers and the public about a possible association between breast implants and a type of anaplastic large cell lymphoma (ALCL). Although ALCL is extremely rare, the FDA believes that women...

Long-Term European Data Released for SUPERA® Stent from IDEV Technologies

January 26, 2011 6:35 am | by Bio-Medicine.Org | Comments

LEIPZIG, Germany, Jan. 26, 2011 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks...


Using Technology to Maximize the Clinician's Role

January 26, 2011 6:33 am | by Diagnostic Imaging | Comments

The iPad and other mobile devices are able to provide access to an enormous amount of information quickly. When combined with the knowledge and expertise of a skilled professional such as a doctor, these tools are amplified in their efficiency. With an iPad, every physician can become an...


New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., Jan. 26, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the...


QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

NEWARK, Del. and HYDERABAD, India, Jan. 26, 2011 /- QPS, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of a majority stake in Bioserve Clinical...


MedCath Corporation to Release First Quarter Results

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., Jan. 26, 2011 /- MedCath Corporation (Nasdaq: MDTH ) will issue a press release after the market closes on February 9, 2011 to announce results from its first fiscal quarter ended December 31, 2010. MedCath has elected not to host a conference call to review its first...


Avantra Biosciences Launches Multiplex System for Faster, Easier Quantification of Cancer Protein Biomarkers

January 26, 2011 6:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 26, 2011 /- Avantra® Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx™ BioChip Immunoassay. The system provides quantitative protein biomarker...


Research shows how pathogenic bacteria hide inside host cells

January 26, 2011 5:31 am | by EurekAlert | Comments

(Wiley-Blackwell) A new study into Staphylococcus aureus, the bacterium which is responsible for severe chronic infections worldwide, reveals how bacteria have developed a strategy of hiding within host cells to escape the immune system as well as many antibacterial treatments. The...


Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Elementâ„¢ Everolimus-Eluting Stent

January 26, 2011 3:32 am | by Boston Scientific | Comments

PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent


STMicroelectronics Reports 2010 Fourth Quarter and Full Year Financial Results

January 26, 2011 2:33 am | by I-Micronews | Comments

?Fourth quarter net revenues increased 6.6% sequentially; 39.9% gross margin ?2010 net income of $830 million on highest ever net revenues of $10.35 billion ?Net financial position improved $732 million in 2010 to $1.15 billion* ?Record year for the full range of ST?s ?Sense and Power?...

WellPoint 4th-quarter net income drops

January 26, 2011 1:45 am | by The Associated Press | Comments

WellPoint says its fourth-quarter net income declined, as the prior-year period included a large gain related to a sale. Its adjusted results beat Wall Street's view.The largest publicly traded health insurer based on enrollment earned $548.8 million, or $1.40 per share, for the three months...

His Highness Sheikh Mohammed bin Zayed Al Nahyan and the Bill & Melinda Gates Foundation Partner to Immunize Children

January 26, 2011 1:34 am | by Bio-Medicine.Org | Comments

SEATTLE and ABU DHABI, United Arab Emirates, Jan. 26, 2011 /PRNewswire-USNewswire/ -- His Highness Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, and Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation,...


Global Genes Project Announces 'Wear That You Careâ„¢' Denim Awareness Campaign for Rare Disease Day 2011

January 26, 2011 1:33 am | by Bio-Medicine.Org | Comments

DANA POINT, Calif., Jan. 26, 2011 /- Monday, February 28, 2011, is the 4th annual Rare Disease Day — a day when people worldwide will show their support for the millions of people suffering from rare diseases and disorders.  According to statistics from the National Institutes...


Arizona companies team up, providing quick development of cancer drugs

January 25, 2011 10:31 pm | by EurekAlert | Comments

(The Translational Genomics Research Institute) TGen Drug Development and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.